Martin Bidlingmaier

20.6k total citations · 1 hit paper
373 papers, 11.4k citations indexed

About

Martin Bidlingmaier is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Physiology. According to data from OpenAlex, Martin Bidlingmaier has authored 373 papers receiving a total of 11.4k indexed citations (citations by other indexed papers that have themselves been cited), including 286 papers in Endocrinology, Diabetes and Metabolism, 90 papers in Surgery and 63 papers in Physiology. Recurrent topics in Martin Bidlingmaier's work include Growth Hormone and Insulin-like Growth Factors (158 papers), Pituitary Gland Disorders and Treatments (100 papers) and Hormonal Regulation and Hypertension (88 papers). Martin Bidlingmaier is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (158 papers), Pituitary Gland Disorders and Treatments (100 papers) and Hormonal Regulation and Hypertension (88 papers). Martin Bidlingmaier collaborates with scholars based in Germany, United States and Switzerland. Martin Bidlingmaier's co-authors include Martín Reincke, Christian J. Strasburger, Felix Beuschlein, Zida Wu, Maximilian Bielohuby, Matthias H. Tschöp, Marcus Quinkler, Bruno Allolio, Evelyn Fischer and R. Landgraf and has published in prestigious journals such as New England Journal of Medicine, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Martin Bidlingmaier

356 papers receiving 11.2k citations

Hit Papers

Post-prandial decrease of circulating human ghrelin levels 2001 2026 2009 2017 2001 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Post-prandial decrease of circulating human ghrelin levels
    2001 555 citations Martin Bidlingmaier et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Martin Bidlingmaier Germany 56 7.0k 3.4k 2.1k 2.0k 1.9k 373 11.4k
Uberto Pagotto Italy 59 5.2k 0.7× 2.3k 0.7× 3.0k 1.4× 2.1k 1.0× 1.8k 1.0× 269 13.3k
Akira Shimatsu Japan 53 4.6k 0.7× 2.1k 0.6× 2.5k 1.1× 2.4k 1.2× 2.6k 1.4× 331 12.5k
Renato Pasquali Italy 61 5.4k 0.8× 1.9k 0.6× 2.5k 1.2× 1.6k 0.8× 1.5k 0.8× 190 15.2k
Márta Korbonits United Kingdom 65 7.0k 1.0× 3.7k 1.1× 3.3k 1.5× 4.2k 2.1× 3.8k 2.0× 422 15.5k
Dariush Elahi United States 56 5.9k 0.8× 3.1k 0.9× 2.8k 1.3× 1.0k 0.5× 2.7k 1.4× 153 10.7k
Darleen A. Sandoval United States 47 2.7k 0.4× 4.1k 1.2× 3.5k 1.6× 2.2k 1.1× 1.7k 0.9× 137 8.1k
Niels Møller Denmark 60 6.3k 0.9× 1.8k 0.5× 5.8k 2.7× 1.7k 0.9× 2.8k 1.4× 368 13.1k
Hanno Pijl Netherlands 60 2.9k 0.4× 1.3k 0.4× 3.8k 1.8× 2.3k 1.1× 1.9k 1.0× 279 10.1k
Robert Frederich United States 33 5.5k 0.8× 2.0k 0.6× 2.9k 1.3× 2.9k 1.4× 2.6k 1.4× 77 10.8k
Emanuela Arvat Italy 54 6.2k 0.9× 1.6k 0.5× 3.6k 1.7× 5.1k 2.5× 1.1k 0.6× 311 11.2k

Countries citing papers authored by Martin Bidlingmaier

Since Specialization
Citations

This map shows the geographic impact of Martin Bidlingmaier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Bidlingmaier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Bidlingmaier more than expected).

Fields of papers citing papers by Martin Bidlingmaier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Bidlingmaier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Bidlingmaier. The network helps show where Martin Bidlingmaier may publish in the future.

Co-authorship network of co-authors of Martin Bidlingmaier

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Bidlingmaier. A scholar is included among the top collaborators of Martin Bidlingmaier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Bidlingmaier. Martin Bidlingmaier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Biller, Beverly M. K., Атанаска Еленкова, César Luiz Boguszewski, et al.. (2025). Rapid and Sustained Response of Biochemically Uncontrolled Acromegaly to Once-daily Oral Paltusotine Treatment. The Journal of Clinical Endocrinology & Metabolism. 111(4). e1050–e1063. 1 indexed citations
2.
Schneider, Holger, et al.. (2024). Fast and reliable quantification of aldosterone, cortisol and cortisone via LC-MS/MS to study 11β-hydroxysteroid dehydrogenase activities in primary cell cultures. The Journal of Steroid Biochemistry and Molecular Biology. 244. 106610–106610.
3.
Heinrich, Daniel, Martin Bidlingmaier, Felix Beuschlein, et al.. (2024). Impact of confirmatory test results on subtype classification and biochemical outcome following unilateral adrenalectomy in patients with primary aldosteronism. Frontiers in Endocrinology. 15. 1495959–1495959. 2 indexed citations
4.
Bidlingmaier, Martin, Sebastian Martini, Katharina Müller, et al.. (2024). Growth hormone treatment in aged patients with comorbidities: A systematic review. Growth Hormone & IGF Research. 75. 101584–101584. 2 indexed citations
5.
Lecoq, Anne-Lise, Katharina Schilbach, L. Rocher, et al.. (2024). Metabolically healthy obesity in adults with X-linked hypophosphatemia. European Journal of Endocrinology. 191(2). 156–165. 3 indexed citations
6.
Biller, Beverly M. K., Атанаска Еленкова, César Luiz Boguszewski, et al.. (2024). 12535 Efficacy And Safety Of Once-daily Oral Paltusotine In Medically Untreated Patients With Acromegaly: Results From The Phase 3, Randomized, Placebo-controlled Pathfndr-2 Study. Journal of the Endocrine Society. 8(Supplement_1). 5 indexed citations
7.
Zhang, Wei, H. Nowotny, Martin Bidlingmaier, et al.. (2023). 11-beta-hydroxysteroid dehydrogenase type 1 (HSD11B1) gene expression in muscle is linked to reduced skeletal muscle index in sarcopenic patients. Aging Clinical and Experimental Research. 35(12). 3073–3083. 4 indexed citations
8.
Podgórski, Rafał, et al.. (2023). Changes of androgen and corticosterone metabolites excretion and conversion in cystic fibrosis. Frontiers in Endocrinology. 14. 1244127–1244127. 2 indexed citations
9.
Auer, Matthias K., H. Nowotny, Christian Lottspeich, et al.. (2023). Synthetic glucocorticoids instead of hydrocortisone do not increase mineralocorticoid needs in adult patients with salt wasting congenital adrenal hyperplasia. The Journal of Steroid Biochemistry and Molecular Biology. 230. 106271–106271. 2 indexed citations
10.
Adolf, Christian, Holger Schneider, Lisa Mueller, et al.. (2023). Postoperative ACTH-stimulated aldosterone predicts biochemical outcome in primary aldosteronism. European Journal of Endocrinology. 189(6). 611–618. 3 indexed citations
11.
Nowotny, H., Leah Braun, Frederick Vogel, et al.. (2022). 11-Oxygenated C19 steroids are the predominant androgens responsible for hyperandrogenemia in Cushing's disease. European Journal of Endocrinology. 187(5). 663–673. 19 indexed citations
12.
Nowotny, H., Matthias K. Auer, Christian Lottspeich, et al.. (2021). Salivary Profiles of 11-oxygenated Androgens Follow a Diurnal Rhythm in Patients With Congenital Adrenal Hyperplasia. The Journal of Clinical Endocrinology & Metabolism. 106(11). e4509–e4519. 17 indexed citations
13.
Maharaj, Avinaash, Jack Williams, Sumana Chatterjee, et al.. (2021). Growth Hormone Receptor (GHR) 6Ω Pseudoexon Activation: A Novel Cause of Severe Growth Hormone Insensitivity. The Journal of Clinical Endocrinology & Metabolism. 107(1). e401–e416. 5 indexed citations
14.
Hinrichs, Arne, Nikolai Klymiuk, Andreas Blutke, et al.. (2020). Growth hormone receptor knockout to reduce the size of donor pigs for preclinical xenotransplantation studies. Xenotransplantation. 28(2). e12664–e12664. 55 indexed citations
15.
Hj, Schneider, et al.. (2019). Initial free cortisol dynamics following blunt multiple trauma and traumatic brain injury: A clinical study. Journal of International Medical Research. 47(3). 1185–1194. 13 indexed citations
16.
Gao, Yuanqing, Maximilian Bielohuby, Thomas Fleming, et al.. (2017). Dietary sugars, not lipids, drive hypothalamic inflammation. Molecular Metabolism. 6(8). 897–908. 98 indexed citations
17.
Cohen‐Barak, Orit, et al.. (2015). The Pharmacokinetics and Pharmacodynamics of TV-1106, a Once Weekly GH Supplement: Results from a Phase 2 Study of TV-1106 in Adults with GH Deficiency. 84.
18.
Tong, Jenny, Ronald L. Prigeon, Harold W. Davis, et al.. (2013). Physiologic Concentrations of Exogenously Infused Ghrelin Reduces Insulin Secretion Without Affecting Insulin Sensitivity in Healthy Humans. The Journal of Clinical Endocrinology & Metabolism. 98(6). 2536–2543. 41 indexed citations
19.
Strasburger, C. J., Martin Bidlingmaier, & Z. Wu. (2005). Detecting growth hormone abuse in athletes. 10. 2 indexed citations
20.
Morrison, Katherine M., Zida Wu, Martin Bidlingmaier, & Christian J. Strasburger. (2001). Findings and theoretical considerations on the usefulness of the acid-labile subunit in the monitoring of acromegaly. Growth Hormone & IGF Research. 11. S61–S63. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Uberto Pagotto Breakdown of academic impact, for papers by Akira Shimatsu Breakdown of academic impact, for papers by Renato Pasquali Breakdown of academic impact, for papers by Márta Korbonits Breakdown of academic impact, for papers by Dariush Elahi Breakdown of academic impact, for papers by Darleen A. Sandoval Breakdown of academic impact, for papers by Niels Møller Breakdown of academic impact, for papers by Hanno Pijl Breakdown of academic impact, for papers by Robert Frederich Breakdown of academic impact, for papers by Emanuela Arvat
Rankless by CCL
2026